What is BioCryst Pharmaceuticals Inc's Market Cap?

BioCryst Pharmaceuticals Inc's Market Cap is $2.3B, based on as-reported figures from SEC (XBRL) filings.

What is BioCryst Pharmaceuticals Inc's Enterprise Value?

BioCryst Pharmaceuticals Inc's Enterprise Value is $2.4B, based on as-reported figures from SEC (XBRL) filings.

What is BioCryst Pharmaceuticals Inc's Price / Sales?

BioCryst Pharmaceuticals Inc's Price / Sales is 2.5×, based on as-reported figures from SEC (XBRL) filings.

What is BioCryst Pharmaceuticals Inc's EV / Revenue?

BioCryst Pharmaceuticals Inc's EV / Revenue is 2.5×, based on as-reported figures from SEC (XBRL) filings.

What is BioCryst Pharmaceuticals Inc's EV / EBITDA?

BioCryst Pharmaceuticals Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is BioCryst Pharmaceuticals Inc's Revenue (TTM)?

BioCryst Pharmaceuticals Inc's Revenue (TTM) is $940.6M, based on as-reported figures from SEC (XBRL) filings.

What is BioCryst Pharmaceuticals Inc's Net Income (TTM)?

BioCryst Pharmaceuticals Inc's Net Income (TTM) is -$384.7M, based on as-reported figures from SEC (XBRL) filings.

What is BioCryst Pharmaceuticals Inc's EBITDA?

BioCryst Pharmaceuticals Inc's EBITDA is -$311.8M, based on as-reported figures from SEC (XBRL) filings.

What is BioCryst Pharmaceuticals Inc's Diluted EPS (TTM)?

BioCryst Pharmaceuticals Inc's Diluted EPS (TTM) is -1.51, based on as-reported figures from SEC (XBRL) filings.

What is BioCryst Pharmaceuticals Inc's EBITDA Margin?

BioCryst Pharmaceuticals Inc's EBITDA Margin is -33.1%, based on as-reported figures from SEC (XBRL) filings.

BioCryst Pharmaceuticals Inc (BCRX) Financial Statements

BioCryst Pharmaceuticals Inc

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001S7K151

XNAS · usd

9.07▼ 0.90 (-8.99%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close9.96

Day's Range8.96 – 9.40

52-Week Range6.00 – 11.22

Volume9.2M

Avg Volume3.2M

Share Statistics

Shares Outstanding

Employees435

ExchangeXNAS

Listed1994-03-03

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about BioCryst Pharmaceuticals Inc (BCRX)

What is BioCryst Pharmaceuticals Inc's Market Cap?: BioCryst Pharmaceuticals Inc's Market Cap is $2.3B, based on as-reported figures from SEC (XBRL) filings.
What is BioCryst Pharmaceuticals Inc's Enterprise Value?: BioCryst Pharmaceuticals Inc's Enterprise Value is $2.4B, based on as-reported figures from SEC (XBRL) filings.
What is BioCryst Pharmaceuticals Inc's Price / Sales?: BioCryst Pharmaceuticals Inc's Price / Sales is 2.5×, based on as-reported figures from SEC (XBRL) filings.
What is BioCryst Pharmaceuticals Inc's EV / Revenue?: BioCryst Pharmaceuticals Inc's EV / Revenue is 2.5×, based on as-reported figures from SEC (XBRL) filings.
What is BioCryst Pharmaceuticals Inc's EV / EBITDA?: BioCryst Pharmaceuticals Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is BioCryst Pharmaceuticals Inc's Revenue (TTM)?: BioCryst Pharmaceuticals Inc's Revenue (TTM) is $940.6M, based on as-reported figures from SEC (XBRL) filings.
What is BioCryst Pharmaceuticals Inc's Net Income (TTM)?: BioCryst Pharmaceuticals Inc's Net Income (TTM) is -$384.7M, based on as-reported figures from SEC (XBRL) filings.
What is BioCryst Pharmaceuticals Inc's EBITDA?: BioCryst Pharmaceuticals Inc's EBITDA is -$311.8M, based on as-reported figures from SEC (XBRL) filings.
What is BioCryst Pharmaceuticals Inc's Diluted EPS (TTM)?: BioCryst Pharmaceuticals Inc's Diluted EPS (TTM) is -1.51, based on as-reported figures from SEC (XBRL) filings.
What is BioCryst Pharmaceuticals Inc's EBITDA Margin?: BioCryst Pharmaceuticals Inc's EBITDA Margin is -33.1%, based on as-reported figures from SEC (XBRL) filings.